Ongoing Research Funded by DHF

Tumor-Promoting Functions for Potential Therapies in Pancreatic Cancer

2021  | Disease: Cancers of the Digestive Tract

Principal Researcher: Beatriz Sosa-Pineda

Principal Investigator: Beatriz Sosa-Pineda, PhD

Pancreatic cancer has one of the worst survival rates in the world, and patients have very limited therapeutic options to fight the disease. It is predicted that close to 47,000 Americans will succumb to pancreatic ductal adenocarcinoma (PDAC) in 2020. Meeting the dire need for new therapies and diagnostic methods requires a better understanding of the fundamental biology of PDAC. Learning more about the molecular mechanisms that govern tumor formation, progression, and spread (metastasis) is critical to improving outcomes. In this study, Dr. Sosa-Pineda intends to build on her lab’s previous findings to firmly establish the role of a new gene regulator, the transcription factor ONECUT2, in the development of pancreatic cancer. This project will use molecular approaches to abolish the expression of ONECUT2 and test its effect on pancreatic tumor function. The Sosa-Pineda team will employ additional approaches to identify specific pathways and functions regulated by ONECUT2 in pancreatic tumors.

Researcher Bio

To receive Digestive Health Foundation updates on research, free education events, and the 2019 Gala, please fill in your information and click 'Submit.'

Thank you, and welcome!

We will not give or sell your contact information to anyone and will only send communications to your inbox when we have exciting news or events to share.